Interventional Oncology Market by Product (Radiofrequency, microwave, cryoablation, embolization, guidewires), Procedures (Thermal Ablation, Non-Thermal Ablation, TACE, TARE, TAE), Cancer (Liver, Lung, Kidney, Bone Metastasis) - Global Forecast to 2024

Interventional Oncology Market by Product (Radiofrequency, microwave, cryoablation, embolization, guidewires), Procedures (Thermal Ablation, Non-Thermal Ablation, TACE, TARE, TAE), Cancer (Liver, Lung, Kidney, Bone Metastasis) - Global Forecast to 2024

“The global interventional oncology market is projected to grow at a CAGR of 6.8% during the forecast period”
Interventional oncology refers to the use of minimally invasive procedures performed for the diagnosis, treatment, or palliative care of cancer. The global interventional oncology market is projected to reach USD 2.9 billion by 2024 from USD 2.0 billion in 2019, at a CAGR of 6.8% from 2019 to 2024. The growth of this market is primarily driven by the rising preference for minimally invasive procedures, expansion of the target patient population, increasing public-private funding and government support for cancer research, technological advancements in the field of interventional oncology, and increasing government investments and funding for interventional oncology and related cancer research. However, the dearth of well-trained and skilled radiologists and oncologists, high costs of interventional oncology procedures, and unfavorable regulations are expected to limit market growth to a certain extent.

“The transcatheter arterial radioembolization TARE or selective internal radiation therapy SIRT segment accounted for the largest share of the global interventional oncology market during the forecast period”
On the basis of procedure, the interventional oncology market is segmented into thermal tumor ablation, non-thermal tumor ablation, transcatheter arterial chemoembolization TACE, transcatheter arterial radioembolization TARE or selective internal radiation therapy SIRT, and transcatheter arterial embolization TAE or bland embolization procedures. In 2018, the TARE/SIRT procedures segment accounted for the largest share of this market majorly due to the rising prevalence of cancer, increasing demand for minimally invasive procedures, growing adoption of embolization procedures, and the clinical efficacy of Yttrium-90 radioembolic agents which are used in these procedures.

“The liver cancer segment accounted for the largest share of the interventional oncology market during the forecast period”
Based on cancer type, the interventional oncology market is segmented into liver cancer, lung cancer, kidney cancer, bone cancer, and other cancers. The other cancers segment includes pediatric cancer, prostate cancer, and breast cancer. The liver cancer segment accounted for the largest share in the interventional oncology market in 2018.

“Europe accounted for the second-largest share of the global market in 2018”
The interventional oncology market is segmented into five major regions, namely North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Europe accounted for the second-largest share in 2018. The rising incidence of cancer, coupled with the growing geriatric population in Europe, is a key factor propelling the demand for interventional oncology products in this region. Prominent market players are focusing on improving the quality of patient care across Europe by commercializing advanced products, investing in technological innovations, and partnering with other institutions and organizations for spreading cancer awareness. This is another major factor driving market growth.

Breakdown of supply-side primary interviews:
By Company Type: Tier 1 - 25%, Tier 2 - 30%, and Tier 3 - 45%
By Designation: C-level - 26%, Director-level - 30%, and Others - 44%
By Region: North America - 34%, Europe - 26%, APAC - 23%, and RoW - 17%

The major players in the market include Medtronic Ireland, Boston Scientific US, BTG plc UK, Merit Medical Systems US, and Terumo Japan. The other prominent players operating in the overall interventional oncology market include AngioDynamics US, Ethicon a part of J&J US, Teleflex US, Cook Medical US, HealthTronics US, MedWaves Medical US, Sanarus US, IMBiotechnologies Canada, Trod Medical US, IceCure Medical Israel, Mermaid Medicals Denmark, and Interface Biomaterials BV Netherlands, among others.

Research Coverage
This report studies the interventional oncology market based on products, procedure, cancer type, and region. The report also studies factors such as drivers, restraints, opportunities, and challenges affecting market growth. It also provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and the respective countries in these regions.

Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market shares of top players, and company profiles, which together form basic views. It also analyzes the competitive landscape; emerging segments of the interventional oncology market; and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
      • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • RESEARCH DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • MARKET SIZE ESTIMATION
      • PRODUCT-BASED MARKET ESTIMATION
      • PRIMARY RESEARCH VALIDATION
    • MARKET BREAKDOWN AND DATA TRIANGULATION
    • RESEARCH LIMITATIONS AND ASSUMPTIONS
      • LIMITATIONS
      • ASSUMPTIONS
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • INTERVENTIONAL ONCOLOGY: MARKET OVERVIEW
    • GEOGRAPHIC ANALYSIS: INTERVENTIONAL ONCOLOGY MARKET, BY PRODUCT
    • ASIA PACIFIC: ABLATION DEVICES MARKET, BY TYPE (2018)
    • EUROPE: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE (2018)
    • INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2019 VS. 2024 (USD MILLION)
    • GEOGRAPHICAL SNAPSHOT OF THE INTERVENTIONAL ONCOLOGY MARKET
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • DRIVERS
      • RESTRAINTS
      • OPPORTUNITIES
      • CHALLENGES
    • MARKET TRENDS
      • PERSONALIZED OR PRECISION INTERVENTIONAL ONCOLOGY
  • INTERVENTIONAL ONCOLOGY MARKET, BY PRODUCT
    • INTRODUCTION
      • Table INTERVENTIONAL ONCOLOGY MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
    • EMBOLIZATION DEVICES
      • Table RECENT PRODUCT LAUNCHES AND APPROVALS OF EMBOLIZATION DEVICES
      • Table INTERVENTIONAL ONCOLOGY EMBOLIZATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
      • Table INTERVENTIONAL ONCOLOGY EMBOLIZATION DEVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
      • INTERVENTIONAL ONCOLOGY EMBOLIZATION DEVICES MARKET SPLIT, BY PROCEDURE
        • Table INTERVENTIONAL ONCOLOGY EMBOLIZATION DEVICES MARKET, BY PROCEDURE, 2017-2024 (USD MILLION)
      • INTERVENTIONAL ONCOLOGY EMBOLIZATION DEVICES MARKET SPLIT, BY CANCER TYPE
        • Table INTERVENTIONAL ONCOLOGY EMBOLIZATION DEVICES MARKET, BY CANCER TYPE, 2017-2024 (USD
      • RADIOEMBOLIC AGENTS
        • Table RADIOEMBOLIC AGENTS OFFERED BY MAJOR MARKET PLAYERS
        • Table RADIOEMBOLIC AGENTS MARKET, BY REGION, 2017-2024 (USD MILLION)
        • Table RADIOEMBOLIC AGENTS MARKET, BY PROCEDURE, 2017-2024 (USD MILLION)
        • Table RADIOEMBOLIC AGENTS MARKET, BY CANCER TYPE, 2017-2024 (USD MILLION)
      • NON-RADIOACTIVE EMBOLIC AGENTS
        • Table NON-RADIOACTIVE EMBOLIC AGENTS OFFERED BY MAJOR MARKET PLAYERS
        • Table NON-RADIOACTIVE EMBOLIC AGENTS MARKET, BY REGION, 2017-2024 (USD MILLION)
        • Table NON-RADIOACTIVE EMBOLIC AGENTS MARKET, BY PROCEDURE, 2017-2024 (USD MILLION)
        • Table NON-RADIOACTIVE EMBOLIC AGENTS MARKET, BY CANCER TYPE, 2017-2024 (USD MILLION)
    • ABLATION DEVICES
      • TECHNOLOGICAL ADVANCEMENTS IN ABLATION DEVICES-A KEY DRIVER FOR MARKET GROWTH
        • Table INTERVENTIONAL ONCOLOGY ABLATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table INTERVENTIONAL ONCOLOGY ABLATION DEVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
        • Table INTERVENTIONAL ONCOLOGY ABLATION DEVICES MARKET, BY PROCEDURE, 2017-2024 (USD MILLION)
        • Table INTERVENTIONAL ONCOLOGY ABLATION DEVICES MARKET, BY CANCER TYPE, 2017-2024 (USD MILLION)
      • RADIOFREQUENCY (RF) ABLATION DEVICES
        • Table RADIOFREQUENCY ABLATION DEVICES OFFERED BY MAJOR MARKET PLAYERS
        • Table RADIOFREQUENCY ABLATION DEVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
        • Table RADIOFREQUENCY ABLATION DEVICES MARKET, BY PROCEDURE, 2017-2024 (USD MILLION)
        • Table RADIOFREQUENCY ABLATION DEVICES MARKET, BY CANCER TYPE, 2017-2024 (USD MILLION)
      • MICROWAVE ABLATION DEVICES
        • Table MICROWAVE ABLATION DEVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
        • Table MICROWAVE ABLATION DEVICES MARKET, BY PROCEDURE, 2017-2024 (USD MILLION)
        • Table MICROWAVE ABLATION DEVICES MARKET, BY CANCER TYPE, 2017-2024 (USD MILLION)
      • CRYOABLATION DEVICES
        • Table CRYOABLATION DEVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
        • Table CRYOABLATION DEVICES MARKET, BY PROCEDURE, 2017-2024 (USD MILLION)
        • Table CRYOABLATION DEVICES MARKET, BY CANCER TYPE, 2017-2024 (USD MILLION)
      • OTHER ABLATION DEVICES
        • Table OTHER ABLATION DEVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
        • Table OTHER ABLATION DEVICES MARKET, BY PROCEDURE, 2017-2024 (USD MILLION)
        • Table OTHER ABLATION DEVICES MARKET, BY CANCER TYPE, 2017-2024 (USD MILLION)
    • SUPPORT DEVICES
      • Table INTERVENTIONAL ONCOLOGY SUPPORT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
      • Table INTERVENTIONAL ONCOLOGY SUPPORT DEVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
      • INTERVENTIONAL ONCOLOGY SUPPORT DEVICES MARKET SPLIT, BY PROCEDURE
        • Table INTERVENTIONAL ONCOLOGY SUPPORT DEVICES MARKET, BY PROCEDURE, 2017-2024 (USD MILLION)
      • INTERVENTIONAL ONCOLOGY SUPPORT DEVICES MARKET SPLIT, BY CANCER TYPE
        • Table INTERVENTIONAL ONCOLOGY SUPPORT DEVICES MARKET, BY CANCER TYPE, 2017-2024 (USD MILLION)
      • MICROCATHETERS
        • Table MICROCATHETERS MARKET, BY REGION, 2017-2024 (USD MILLION)
        • Table MICROCATHETERS MARKET, BY PROCEDURE, 2017-2024 (USD MILLION)
        • Table MICROCATHETERS MARKET, BY CANCER TYPE, 2017-2024 (USD MILLION)
      • GUIDEWIRES
        • Table GUIDEWIRES MARKET, BY REGION, 2017-2024 (USD MILLION)
        • Table GUIDEWIRES MARKET, BY PROCEDURE, 2017-2024 (USD MILLION)
        • Table GUIDEWIRES MARKET, BY CANCER TYPE, 2017-2024 (USD MILLION)
  • INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE
    • INTRODUCTION
      • Table INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2017-2024 (USD MILLION)
    • THERMAL TUMOR ABLATION
      • INCREASING CLINICAL EVIDENCE IS A MAJOR FACTOR DRIVING MARKET GROWTH
        • Table THERMAL TUMOR ABLATION PROCEDURES MARKET, BY REGION, 2017-2024 (USD MILLION)
    • NON-THERMAL TUMOR ABLATION
      • NANOKNIFE HAS EMERGED AS A POTENTIAL ALTERNATIVE TO THERMAL TUMOR ABLATION TECHNIQUES
        • Table NON-THERMAL TUMOR ABLATION PROCEDURES MARKET, BY REGION, 2017-2024 (USD MILLION)
    • TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION
      • ABILITY TO TREAT SMALL AND LARGE-SIZED TUMORS - A MAJOR FACTOR DRIVING THE DEMAND FOR TACE PROCEDURES
        • Table TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION PROCEDURES MARKET, BY REGION, 2017-2024 (USD
    • TRANSCATHETER ARTERIAL RADIOEMBOLIZATION/SELECTIVE INTERNAL RADIATION THERAPY
      • TARE SHOWS GREATER CLINICAL EFFICACY AS COMPARED TO TACE
        • Table TRANSCATHETER ARTERIAL RADIOEMBOLIZATION/SELECTIVE INTERNAL RADIATION THERAPY
    • TRANSCATHETER ARTERIAL EMBOLIZATION/BLAND EMBOLIZATION
      • INCREASING CLINICAL EVIDENCE FOR TARE AND TACE TO RESTRAIN GROWTH OF THIS MARKET
        • Table TRANSCATHETER ARTERIAL EMBOLIZATION/BLAND EMBOLIZATION PROCEDURES MARKET, BY REGION,
  • INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE
    • INTRODUCTION
      • Table INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2017-2024 (USD MILLION)
      • LIVER CANCER
        • Table INTERVENTIONAL ONCOLOGY MARKET FOR LIVER CANCER, BY REGION, 2017-2024 (USD MILLION)
      • LUNG CANCER
        • Table INTERVENTIONAL ONCOLOGY MARKET FOR LUNG CANCER, BY REGION, 2017-2024 (USD MILLION)
      • BONE CANCER
        • Table INTERVENTIONAL ONCOLOGY MARKET FOR BONE CANCER, BY REGION, 2017-2024 (USD MILLION)
      • KIDNEY CANCER
        • Table INTERVENTIONAL ONCOLOGY MARKET FOR KIDNEY CANCER, BY REGION, 2017-2024 (USD MILLION)
      • OTHER CANCERS
        • Table INTERVENTIONAL ONCOLOGY MARKET FOR OTHER CANCERS, BY REGION, 2017-2024 (USD MILLION)
  • INTERVENTIONAL ONCOLOGY MARKET, BY REGION
    • INTRODUCTION
      • Table INTERVENTIONAL ONCOLOGY MARKET, BY REGION, 2017-2024 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: INTERVENTIONAL ONCOLOGY MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
      • Table NORTH AMERICA: INTERVENTIONAL ONCOLOGY MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
      • Table NORTH AMERICA: INTERVENTIONAL ONCOLOGY ABLATION DEVICES MARKET, BY TYPE, 2017-2024 (USD
      • Table NORTH AMERICA: INTERVENTIONAL ONCOLOGY EMBOLIZATION DEVICES MARKET, BY TYPE, 2017-2024 (USD
      • Table NORTH AMERICA: INTERVENTIONAL ONCOLOGY SUPPORT DEVICES MARKET, BY TYPE, 2017-2024 (USD
      • Table NORTH AMERICA: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2017-2024 (USD MILLION)
      • Table NORTH AMERICA: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2017-2024 (USD MILLION)
      • US
        • Table US: INTERVENTIONAL ONCOLOGY MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
        • Table US: INTERVENTIONAL ONCOLOGY ABLATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table US: INTERVENTIONAL ONCOLOGY EMBOLIZATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table US: INTERVENTIONAL ONCOLOGY SUPPORT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
      • CANADA
        • Table CANADA: INTERVENTIONAL ONCOLOGY MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
        • Table CANADA: INTERVENTIONAL ONCOLOGY ABLATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table CANADA: INTERVENTIONAL ONCOLOGY EMBOLIZATION DEVICES MARKET, BY TYPE, 2017-2024 (USD
        • Table CANADA: INTERVENTIONAL ONCOLOGY SUPPORT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
    • EUROPE
      • Table EUROPE: INTERVENTIONAL ONCOLOGY MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
      • Table EUROPE: INTERVENTIONAL ONCOLOGY MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
      • Table EUROPE: INTERVENTIONAL ONCOLOGY ABLATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
      • Table EUROPE: INTERVENTIONAL ONCOLOGY EMBOLIZATION DEVICES MARKET, BY TYPE, 2017-2024 (USD
      • Table EUROPE: INTERVENTIONAL ONCOLOGY SUPPORT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
      • Table EUROPE: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2017-2024 (USD MILLION)
      • Table EUROPE: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2017-2024 (USD MILLION)
      • GERMANY
        • Table GERMANY: INTERVENTIONAL ONCOLOGY MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
        • Table GERMANY: INTERVENTIONAL ONCOLOGY ABLATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table GERMANY: INTERVENTIONAL ONCOLOGY EMBOLIZATION DEVICES MARKET, BY TYPE, 2017-2024 (USD
        • Table GERMANY: INTERVENTIONAL ONCOLOGY SUPPORT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
      • UK
        • Table UK: INTERVENTIONAL ONCOLOGY MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
        • Table UK: INTERVENTIONAL ONCOLOGY ABLATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table UK: INTERVENTIONAL ONCOLOGY EMBOLIZATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table UK: INTERVENTIONAL ONCOLOGY SUPPORT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
      • FRANCE
        • Table FRANCE: INTERVENTIONAL ONCOLOGY MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
        • Table FRANCE: INTERVENTIONAL ONCOLOGY ABLATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table FRANCE: INTERVENTIONAL ONCOLOGY EMBOLIZATION DEVICES MARKET, BY TYPE, 2017-2024 (USD
        • Table FRANCE: INTERVENTIONAL ONCOLOGY SUPPORT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
      • REST OF EUROPE
        • Table ROE: INTERVENTIONAL ONCOLOGY MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
        • Table ROE: INTERVENTIONAL ONCOLOGY ABLATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table ROE: INTERVENTIONAL ONCOLOGY EMBOLIZATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table ROE: INTERVENTIONAL ONCOLOGY SUPPORT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
    • ASIA PACIFIC
      • Table ASIA PACIFIC: INTERVENTIONAL ONCOLOGY MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
      • Table ASIA PACIFIC: INTERVENTIONAL ONCOLOGY MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
      • Table ASIA PACIFIC: INTERVENTIONAL ONCOLOGY ABLATION DEVICES MARKET, BY TYPE, 2017-2024 (USD
      • Table ASIA PACIFIC: INTERVENTIONAL ONCOLOGY EMBOLIZATION DEVICES MARKET, BY TYPE, 2017-2024 (USD
      • Table ASIA PACIFIC: INTERVENTIONAL ONCOLOGY SUPPORT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
      • Table ASIA PACIFIC: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2017-2024 (USD MILLION)
      • Table ASIA PACIFIC: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2017-2024 (USD MILLION)
      • JAPAN
        • Table JAPAN: INTERVENTIONAL ONCOLOGY MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
        • Table JAPAN: INTERVENTIONAL ONCOLOGY ABLATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table JAPAN: INTERVENTIONAL ONCOLOGY EMBOLIZATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table JAPAN: INTERVENTIONAL ONCOLOGY SUPPORT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
      • CHINA
        • Table CHINA: INTERVENTIONAL ONCOLOGY MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
        • Table CHINA: INTERVENTIONAL ONCOLOGY ABLATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table CHINA: INTERVENTIONAL ONCOLOGY EMBOLIZATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table CHINA: INTERVENTIONAL ONCOLOGY SUPPORT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
      • INDIA
        • Table INDIA: INTERVENTIONAL ONCOLOGY MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
        • Table INDIA: INTERVENTIONAL ONCOLOGY ABLATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table INDIA: INTERVENTIONAL ONCOLOGY EMBOLIZATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table INDIA: INTERVENTIONAL ONCOLOGY SUPPORT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
      • REST OF ASIA PACIFIC
        • Table ROAPAC: INTERVENTIONAL ONCOLOGY MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
        • Table ROAPAC: INTERVENTIONAL ONCOLOGY ABLATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table ROAPAC: INTERVENTIONAL ONCOLOGY EMBOLIZATION DEVICES MARKET, BY TYPE, 2017-2024 (USD
        • Table ROAPAC: INTERVENTIONAL ONCOLOGY SUPPORT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
    • LATIN AMERICA
      • Table LATAM: INTERVENTIONAL ONCOLOGY MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
      • Table LATAM: INTERVENTIONAL ONCOLOGY MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
      • Table LATAM: INTERVENTIONAL ONCOLOGY ABLATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
      • Table LATAM: INTERVENTIONAL ONCOLOGY EMBOLIZATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
      • Table LATAM: INTERVENTIONAL ONCOLOGY SUPPORT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
      • Table LATAM: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2017-2024 (USD MILLION)
      • Table LATAM: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2017-2024 (USD MILLION)
      • BRAZIL
        • Table BRAZIL: INTERVENTIONAL ONCOLOGY MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
        • Table BRAZIL: INTERVENTIONAL ONCOLOGY ABLATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table BRAZIL: INTERVENTIONAL ONCOLOGY EMBOLIZATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table BRAZIL: INTERVENTIONAL ONCOLOGY SUPPORT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
      • MEXICO
        • Table MEXICO: INTERVENTIONAL ONCOLOGY MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
        • Table MEXICO: INTERVENTIONAL ONCOLOGY ABLATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table MEXICO: INTERVENTIONAL ONCOLOGY EMBOLIZATION DEVICES MARKET, BY TYPE, 2017-2024 (USD
        • Table MEXICO: INTERVENTIONAL ONCOLOGY SUPPORT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
      • REST OF LATIN AMERICA
        • Table ROLA: INTERVENTIONAL ONCOLOGY MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
        • Table ROLA: INTERVENTIONAL ONCOLOGY ABLATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table ROLA: INTERVENTIONAL ONCOLOGY EMBOLIZATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table ROLA: INTERVENTIONAL ONCOLOGY SUPPORT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
    • MIDDLE EAST AND AFRICA
      • IMPROVING HEALTHCARE INFRASTRUCTURE AND RISING INCIDENCE OF CANCER ARE DRIVING GROWTH IN THE MIDDLE EAST AND AFRICA
        • Table MEA: INTERVENTIONAL ONCOLOGY MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
        • Table MEA: INTERVENTIONAL ONCOLOGY ABLATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table MEA: INTERVENTIONAL ONCOLOGY EMBOLIZATION DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table MEA: INTERVENTIONAL ONCOLOGY SUPPORT DEVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table MEA: INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE, 2017-2024 (USD MILLION)
        • Table MEA: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE, 2017-2024 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • GLOBAL MARKET SHARE ANALYSIS, 2017
    • COMPETITIVE SCENARIO (2015 - 2019)
      • KEY PRODUCT LAUNCHES
      • KEY ACQUISITIONS
      • KEY AGREEMENTS AND COLLABORATIONS
    • VENDOR DIVE OVERVIEW
    • VENDOR INCLUSION CRITERIA
    • VENDOR DIVE
      • VANGUARDS
      • INNOVATORS
      • DYNAMIC DIFFERENTIATORS
      • EMERGING COMPANIES
  • COMPANY PROFILES
    • HEALTHTRONICS, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • TROD MEDICAL
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • SANARUS TECHNOLOGIES, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • TELEFLEX, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • IMBIOTECHNOLOGIES LTD.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • MEDWAVES, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • ICECURE MEDICAL
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • TERUMO CORPORATION
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • MEDTRONIC PLC
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • BTG PLC
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • JOHNSON & JOHNSON
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • MERIT MEDICAL SYSTEMS, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • BOSTON SCIENTIFIC CORPORATION
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • ANGIODYNAMICS, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • COOK MEDICAL
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
  • APPENDIX
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook